UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

PR86 Opening Pandora's box – are needs of information about cancer-related changes in sexuality met?

Breast (Edinburgh), 2014-11, Vol.23, p.S29-S29

2014

Volltextzugriff (PDF)

The direct inhibition of MMP-2 and MMP-9 by an enzyme alginogel: a possible mechanism of healing support for venous leg ulcers

Journal of wound care, 2014-05, Vol.23 (5), p.278, 280

2014

Volltextzugriff (PDF)

1429P Impact of previous health-related events on coping with cancer

Annals of oncology, 2022-09, Vol.33, p.S1198

2022

Volltextzugriff (PDF)

194P Follow up after breast cancer in real life

Annals of oncology, 2020-05, Vol.31, p.S86-S86

2020

Volltextzugriff (PDF)

PO27 HER2 and steroid receptor status in pregnancy-associated breast cancer

Breast (Edinburgh), 2012-11, Vol.21, p.S10-S10

2012

Volltextzugriff (PDF)

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers

BMC cancer, 2008-04, Vol.8 (1), p.100-100, Article 100

2008

Volltextzugriff (PDF)

PR33 Assessment of prognostic markers in young women with breast cancer

Breast (Edinburgh), 2012-11, Vol.21, p.S12-S12

2012

Volltextzugriff (PDF)

Quantitative Measurements of Tumoral p95HER2 Protein Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab: Independent Validation of the p95HER2 Clinical Cutoff

Clinical cancer research, 2014-05, Vol.20 (10), p.2805-2813

2014

Volltextzugriff (PDF)

The impact of chemotheraphy and supervised high-intensity interval physical activity on left ventricle strain and myocardial work parameters – SPORT NATHY TRIAL pilot study results

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

192P Strategies and results of oncofertility counselling in young breast cancer patients

Annals of oncology, 2020-05, Vol.31, p.S85-S85

2020

Volltextzugriff (PDF)

73P microRNA expression profiles of single hormone receptor-positive breast cancers

Annals of oncology, 2020-05, Vol.31, p.S39-S40

2020

Volltextzugriff (PDF)

Matrix metalloproteinases in the wound microenvironment: therapeutic perspectives

Chronic wound care management and research, 2016-03, Vol.3 (Issue 1), p.29-39

2016

Volltextzugriff (PDF)

P183 Return to work after adjuvant treatment for breast cancer

Breast (Edinburgh), 2007, Vol.16, p.S65-S65

2007

Volltextzugriff (PDF)

520 Obesity as a risk factor of earlier occurrence of contralateral breast cancer

European journal of cancer supplements, 2010, Vol.8 (3), p.211-212

2010

Volltextzugriff (PDF)

Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland

Contemporary oncology (Poznań, Poland), 2014-01, Vol.18 (6), p.419-424

2014

Volltextzugriff (PDF)

Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project

Contemporary oncology (Poznań, Poland), 2014-01, Vol.18 (6), p.425-428

2014

Volltextzugriff (PDF)

Abstract P3-12-09: The risk of brain metastases according to expression of selected immunohistochemical markers in primary breast cancers

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P3-P3-12-09

2012

Volltextzugriff (PDF)

Abstract P3-13-03: Molecular factors associated with bone metastases in breast cancer patients

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P3-P3-13-03

2012

Volltextzugriff (PDF)

Abstract P2-10-31: Correlation of quantitative p95HER2 and total HER2 levels with clinical outcomes in a combined analysis of two cohorts of trastuzumab-treated metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P2-P2-10-31

2012

Volltextzugriff (PDF)

Steroid hormone status and HER2/neu expression in pregnancy-associated breast cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.21115-21115

2007

Volltextzugriff (PDF)

P5-01-06: Gene Copy Number and Expression of TYMP and TYMS Are Predictive of Outcome in Breast Cancer Patients Treated with Capecitabine

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P5-P5-01-06

2011

Volltextzugriff (PDF)

P2-12-05: Correlation between Quantitative HER2 Protein Expression and Risk of Brain Metastases in HER2−Positive Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P2-P2-12-05

2011

Volltextzugriff (PDF)

Expression of hormone receptors ERα, ERβ and PgR in HER2-positive breast cancers

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10525-10525

2006

Volltextzugriff (PDF)

Thymidilate synthase gene copy number as predictive marker of capecitabine efficacy in patients with breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10629-10629

2011

Volltextzugriff (PDF)

Quantitative measurements of p95HER2 (p95) and total HER2 (H2T) protein expression in patients with trastuzumab-treated, metastatic breast cancer (MBC): Independent confirmation of clinical cutoffs

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.586-586

2011

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(49)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(14)
Humans
(8)
Oncology
(8)
Female
(6)
Male
(6)
Middle Aged
(6)
Hematology, Oncology And Palliative Medicine
(5)
Aged
(4)
Breast Cancer
(4)
Cancer
(4)
Adult
(3)
Aged, 80 And Over
(3)
Breast Neoplasms - Genetics
(3)
Breast Neoplasms - Metabolism
(3)
Disease-Free Survival
(3)
Gene Expression
(3)
Immunohistochemistry
(3)
Prognosis
(3)
Animals
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PR86 Opening Pandora's box – are needs of information about cancer-related changes in sexuality met?

The direct inhibition of MMP-2 and MMP-9 by an enzyme alginogel: a possible mechanism of healing support for venous leg ulcers

1429P Impact of previous health-related events on coping with cancer

194P Follow up after breast cancer in real life

PO27 HER2 and steroid receptor status in pregnancy-associated breast cancer

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers

PR33 Assessment of prognostic markers in young women with breast cancer

Quantitative Measurements of Tumoral p95HER2 Protein Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab: Independent Validation of the p95HER2 Clinical Cutoff

The impact of chemotheraphy and supervised high-intensity interval physical activity on left ventricle strain and myocardial work parameters – SPORT NATHY TRIAL pilot study results

192P Strategies and results of oncofertility counselling in young breast cancer patients

73P microRNA expression profiles of single hormone receptor-positive breast cancers

Matrix metalloproteinases in the wound microenvironment: therapeutic perspectives

P183 Return to work after adjuvant treatment for breast cancer

520 Obesity as a risk factor of earlier occurrence of contralateral breast cancer

Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland

Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project

Abstract P3-12-09: The risk of brain metastases according to expression of selected immunohistochemical markers in primary breast cancers

Abstract P3-13-03: Molecular factors associated with bone metastases in breast cancer patients

Abstract P2-10-31: Correlation of quantitative p95HER2 and total HER2 levels with clinical outcomes in a combined analysis of two cohorts of trastuzumab-treated metastatic breast cancer patients

Steroid hormone status and HER2/neu expression in pregnancy-associated breast cancer

P5-01-06: Gene Copy Number and Expression of TYMP and TYMS Are Predictive of Outcome in Breast Cancer Patients Treated with Capecitabine

P2-12-05: Correlation between Quantitative HER2 Protein Expression and Risk of Brain Metastases in HER2−Positive Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy

Expression of hormone receptors ERα, ERβ and PgR in HER2-positive breast cancers

Thymidilate synthase gene copy number as predictive marker of capecitabine efficacy in patients with breast cancer

Quantitative measurements of p95HER2 (p95) and total HER2 (H2T) protein expression in patients with trastuzumab-treated, metastatic breast cancer (MBC): Independent confirmation of clinical cutoffs

Suchergebnisse filtern